The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast

References

• Almirante B, Rodriguez D, Park BJ, et al. Epidemiology and predictors of mortality in cases of Candidabloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2005; 43: 1829–1835.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Taramasso L, Nicco E, et al. Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One 2011; 6: e24198.
   PubMed Web of Science ®Google Scholar
• Silva S, Negri M, Henriques M, et al. Candida glabrata, Candida parapsilosisand Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev 2012; 36: 288–305.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M. Candidabloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008–2009. Antimicrob Agents Chemother 2011; 55: 561–566.
   PubMed Web of Science ®Google Scholar
• Colombo AL, Nucci M, Park BJ, et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 2006; 44: 2816–2823.
   PubMed Web of Science ®Google Scholar
• Peman J, Canton E, Quindos G, et al. Epidemiology, species distribution and in vitroantifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother 2012; 67: 1181–1187.
   PubMed Web of Science ®Google Scholar
• Negri M, Silva S, Henriques M, Oliveira R. Insights into Candida tropicalisnosocomial infections and virulence factors. Eur J Clin Microbiol Infect Dis 2012; 31: 1399–1412.
   PubMed Web of Science ®Google Scholar
• Muñoz P, Giannella M, Fanciulli C, et al. Candida tropicalisfungaemia: incidence, risk factors and mortality in a general hospital. Clin Microbiol Infect 2011; 17: 1538–1545.
   Google Scholar
• Cuenca-Estrella M, Gomez-Lopez A, Cuesta I, et al. Frequency of voriconazole resistance in vitroamong Spanish clinical isolates of Candidaspp. according to breakpoints established by the Antifungal Subcommittee of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother 2011; 55: 1794–1797.
   Google Scholar
• Tortorano AM, Prigitano A, Dho G, Grancini A, Passera M. Antifungal susceptibility profiles of Candidaisolates from a prospective survey of invasive fungal infections in Italian intensive care units. J Med Microbiol 2012; 61: 389–393.
   Google Scholar
• Schmalreck AF, Willinger B, Haase G, et al. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study. Mycoses 2012; 55: e124–137.
   Google Scholar
• Okawa Y, Miyauchi M, Kobayashi H. Comparison of pathogenicity of various Candida tropicalisstrains. Biol Pharm Bull 2008; 31: 1507–1510.
   PubMed Web of Science ®Google Scholar
• Marine M, Pastor FJ, Guarro J. Efficacy of posaconazole in a murine disseminated infection by Candida tropicalis. Antimicrob Agents Chemother 2010; 54: 530–532.
   Google Scholar
• Mylonakis E, Aballay A. Worms and flies as genetically tractable animal models to study host-pathogen interactions. Infect Immun 2005; 73: 3833–3841.
   PubMed Web of Science ®Google Scholar
• Chrisman CJ, Albuquerque P, Guimaraes AJ, Nieves E, Casadevall A. Phospholipids trigger Cryptococcus neoformanscapsular enlargement during interactions with amoebae and macrophages. PLoS Pathog 2011; 7: e1002047.
   PubMed Web of Science ®Google Scholar
• Muhammed M, Fuchs BB, Wu MP, et al. The role of mycelium production and a MAPK-mediated immune response in the C. elegans-Fusarium model system. Med Mycol 2012; 50: 488–496.
   PubMed Web of Science ®Google Scholar
• Cotter G, Doyle S, Kavanagh K. Development of an insect model for the in vivopathogenicity testing of yeasts. FEMS Immunol Med Microbiol 2000; 27: 163–169.
   PubMed Web of Science ®Google Scholar
• Mylonakis E, Moreno R, El Khoury JB, et al. Galleria mellonellaas a model system to study Cryptococcus neoformanspathogenesis. Infect Immun 2005; 73: 3842–3850.
   PubMed Web of Science ®Google Scholar
• Garcia-Rodas R, Casadevall A, Rodriguez-Tudela JL, Cuenca-Estrella M, Zaragoza O. Cryptococcus neoformanscapsular enlargement and cellular gigantism during Galleria mellonellainfection. PLoS One 2011; 6: e24485.
   PubMed Web of Science ®Google Scholar
• Brennan M, Thomas DY, Whiteway M, Kavanagh K. Correlation between virulence of Candida albicansmutants in mice and Galleria mellonellalarvae. FEMS Immunol Med Microbiol 2002; 34: 153–157.
   PubMed Web of Science ®Google Scholar
• Cheema MS, Christians JK. Virulence in an insect model differs between mating types in Aspergillus fumigatus. Med Mycol 2011; 49: 202–207.
   PubMed Web of Science ®Google Scholar
• Kelly J, Kavanagh K. Caspofungin primes the immune response of the larvae of Galleria mellonellaand induces a non-specific antimicrobial response. J Med Microbiol 2011; 60: 189–196.
   PubMed Web of Science ®Google Scholar
• Lionakis MS. Drosophilaand Galleriainsect model hosts: new tools for the study of fungal virulence, pharmacology and immunology. Virulence 2011; 2: 521–527.
   PubMed Web of Science ®Google Scholar
• Cowen LE, Singh SD, Kohler JR, et al. Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc Natl Acad Sci USA 2009; 106: 2818–2823.
   PubMed Web of Science ®Google Scholar
• Fuchs BB, Mylonakis E. Using non-mammalian hosts to study fungal virulence and host defense. Curr Opin Microbiol 2006; 9: 346–351.
   PubMed Web of Science ®Google Scholar
• Kavanagh K, Reeves EP. Exploiting the potential of insects for in vivopathogenicity testing of microbial pathogens. FEMS Microbiol Rev 2004; 28: 101–112.
   PubMed Web of Science ®Google Scholar
• Vilmos P, Kurucz E. Insect immunity: evolutionary roots of the mammalian innate immune system. Immunol Lett 1998; 62: 59–66.
   PubMed Web of Science ®Google Scholar
• Ratcliffe NA. Invertebrate immunity – a primer for the non-specialist. Immunol Lett 1985; 10: 253–270.
   PubMed Web of Science ®Google Scholar
• Coleman JJ, Muhammed M, Kasperkovitz PV, Vyas JM, Mylonakis E. Fusariumpathogenesis investigated using Galleria mellonellaas a heterologous host. Fungal Biol 2011; 115: 1279–1289.
   PubMed Web of Science ®Google Scholar
• Peleg AY, Jara S, Monga D, et al. Galleria mellonellaas a model system to study Acinetobacter baumanniipathogenesis and therapeutics. Antimicrob Agents Chemother 2009; 53: 2605–2609.
   PubMed Web of Science ®Google Scholar
• Bergin D, Brennan M, Kavanagh K. Fluctuations in haemocyte density and microbial load may be used as indicators of fungal pathogenicity in larvae of Galleria mellonella. Microbes Infect 2003; 5: 1389–1395.
   PubMed Web of Science ®Google Scholar
• Fuchs BB, O’Brien E, Khoury JB, Mylonakis E. Methods for using Galleria mellonellaas a model host to study fungal pathogenesis. Virulence 2010; 1: 475–482.
   PubMed Web of Science ®Google Scholar
• Tojo S, Naganuma F, Arakawa K, Yokoo S. Involvement of both granular cells and plasmatocytes in phagocytic reactions in the greater wax moth, Galleria mellonella. J Insect Physiol 2000; 46: 1129–1135.
   PubMed Web of Science ®Google Scholar
• Kurtzman CP, Fell JW. The Yeasts: A Taxonomical Study. Amsterdam: Elsevier, 1997.
   Google Scholar
• Glavis-Bloom J, Muhammed M, Mylonakis E. Of model hosts and man: using Caenorhabditis elegans, Drosophila melanogasterand Galleria mellonellaas model hosts for infectious disease research. Adv Exp Med Biol 2012; 710: 11–17.
   PubMed Web of Science ®Google Scholar
• Whiteway M, Oberholzer U. Candidamorphogenesis and host- pathogen interactions. Curr Opin Microbiol 2004; 7: 350–357.
   PubMed Web of Science ®Google Scholar
• Romani L, Bistoni F, Puccetti P. Adaptation of Candida albicansto the host environment: the role of morphogenesis in virulence and survival in mammalian hosts. Curr Opin Microbiol 2003; 6: 338–343.
   PubMed Web of Science ®Google Scholar
• Filler SG, Sheppard DC. Fungal invasion of normally non-phagocytic host cells. PLoS Pathog 2006; 2: e129.
   PubMed Web of Science ®Google Scholar
• Gow NA, van de Veerdonk FL, Brown AJ, Netea MG. Candida albicansmorphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol 2011; 10: 112–122.
   PubMed Web of Science ®Google Scholar
• Moyes DL, Runglall M, Murciano C, et al. A biphasic innate immune MAPK response discriminates between the yeast and hyphal forms of Candida albicansin epithelial cells. Cell Host Microbe 2010; 8: 225–235.
   PubMed Web of Science ®Google Scholar
• Mowlds P, Kavanagh K. Effect of pre-incubation temperature on susceptibility of Galleria mellonellalarvae to infection by Candida albicans. Mycopathologia 2008; 165: 5–12.
   PubMed Web of Science ®Google Scholar